Table 1 Timeframe of the study
Study Phase | Tasks | 2023 | 2024 | 2025 | 2026 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
quarter (proposed trial duration) | |||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | ||
Execution | Screening and inclusion period | ||||||||||||||||
3 months follow-up | |||||||||||||||||
possible extended Follow-Up | |||||||||||||||||
Analysis | Final data analysis | ||||||||||||||||
preparataion of manuscript | |||||||||||||||||